Boxer Capital’s Mersana Therapeutics MRSN Stock Holding History

Boxer Capital’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-72,680	Closed	-$3.43M	–	30
2024 Q3	$3.43M	Buy	+72,680	New	+$3.21M	0.17%	57
2023 Q4	–	Sell	-80,000	Closed	-$2.54M	–	63
2023 Q3	$2.54M	Buy	80,000 +40,000	+100%	+$1.9M	0.14%	55
2023 Q2	$3.29M	Buy	+40,000	New	+$5.85M	0.15%	59
2019 Q4	–	Sell	-67,232	Closed	-$2.66M	–	54
2019 Q3	$2.66M	Sell	67,232 -16,128	-19%	-$1.17M	0.19%	44
2019 Q2	$8.44M	Buy	+83,360	New	+$9.82M	0.74%	26

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return